S. Ashton

Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging

Simon P. Robinson, Dominick J. O. McIntyre, D. Checkley et al. · British Journal of Cancer · 2003 · 110 citations · Full text

Medicine, Oncology, Pharmacology +14

Phenylethylaminergic mechanisms in attention-deficit disorder

Glen B. Baker, Robert A. Bornstein, A. C. Rouget et al. · Biological Psychiatry · 1991 · 84 citations

Medicine, Neuroscience, Pharmacology +13

ZD1839, AN EPIDERMAL GROWTH FACTOR TYROSINE KINASE INHIBITOR SELECTED FOR CLINICAL DEVELOPMENT

J.R. Woodburn, Andrew Barker, Keith H. Gibson et al. · Journal of Immunotherapy · 1997 · 66 citations

Medicine, Oncology, Pharmacology +7

A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis

Boni E. Elewski, Richard Pollak, S. Ashton et al. · British Journal of Dermatology · 2011 · 63 citations

Medicine, Dermatology, Pharmacology +17

Epidermal growth factor receptor tyrosine kinase: Structure-activity relationships and antitumour activity of novel quinazolines

Keith H. Gibson, Walter Grundy, Andrew A. Godfrey et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 55 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14